Highly stable veterinary liquid solutions optimized for simple administration in tropical climates. Formulated under strict international GMP guidelines to guarantee maximum pharmacokinetic absorption.
Understanding the micro and macroeconomics of supplying oral therapeutic drugs to Central Africa's fastest-growing agricultural corridor.
The Democratic Republic of the Congo (DRC) represents a vast, strategically vital market for veterinary oral medicines and active pharmaceutical ingredients (APIs). With expanding livestock production sectors in provinces like Kongo Central, Kinshasa, Kivu, and Katanga, the demand for highly stable, easy-to-administer oral formulations has escalated. However, importing and distributing pharmaceuticals in the DRC presents unique hurdles, notably cold chain logistics vulnerabilities, supply chain fragmentation, and varying humidity levels that accelerate degradation in low-stability chemical formulations.
Our localized focus centers on bridging the gap between state-of-the-art Chinese synthesis and the practical reality of distributors in Kinshasa, Matadi, and Lubumbashi. By engineering liquid oral solutions with advanced thermal stabilizers, we ensure that veterinary therapeutics survive regional transit and retain 100% bio-efficacy upon reach. From anti-parasitic control to respiratory therapeutic interventions, our products support food safety and security initiatives across the Congo basin.
A trusted global partner offering comprehensive active pharmaceutical ingredients, custom synthesis, and quality management consulting.
Based in the high-tech industrial hub of Hangzhou, Zhejiang Province, Hangzhou Jeci Biochem Technology Co., Ltd. is committed to the sales of active pharmaceutical ingredients (APIs), key pharmaceutical intermediates, nutritional products, and specialized food additives. Our core competencies encompass cooperative research & development, custom manufacturing under contract, global export sales, and regulatory compliance consulting.
Within China, we operate a sophisticated, collaborative R&D network in alignment with national pharmaceutical research institutes and specialized production facilities. This ecosystem allows us to support product applications, coordinate technology transfers, supply raw materials, and act as an exclusive agent for highly specialized molecular compounds across global regions.
On the international stage, we have established long-term business ties with leading organizations in India, Southeast Asia, South Korea, Japan, and European hubs. We provide clients with end-to-end guidance, from laboratory sourcing through to final market registry, helping scale distribution channels efficiently.
Integrating chemical raw material supply chains with downstream pharmaceutical synthesis for custom manufacturing.
Our product groups and active raw materials are optimized for multiple industrial processes. We supply critical components that serve as the foundational backbone for finished oral therapeutic formulations:
Key building blocks for active pharmaceutical molecules.
Ensuring steady supply for heavy chemical synthesis pipelines.
Processed under rigorous purity profiles and quality audits.
Essential precursors for target therapeutic drug manufacturing.
Our production assets guarantee stable molecular structures, precise custom batch limits, and high-efficiency synthesis.
To support high-purity pharmaceutical manufacturing, our collaborative factories feature modern batch processors, high-performance liquid chromatography (HPLC) units, gas chromatography systems, and advanced crystallization reactors. We specialize in custom manufacturing projects, assisting clients in synthesizing custom molecular weights, specialized intermediates, and customized APIs within predictable timeframes.
Moreover, Hangzhou Jeci Biochem Technology provides comprehensive factory quality management system certification consulting services. We guide overseas and domestic production lines through WHO-GMP, ISO, and regional regulatory audits, ensuring that all production facilities meet strict quality standards.
Targeting practical agricultural and clinical veterinary scenarios across the Democratic Republic of the Congo.
High humidity and density in regional poultry units increase the risk of coccidiosis and respiratory issues. Our water-soluble oral solutions (such as Toltrazuril and Diclazuril) allow for mass administration via centralized watering systems, protecting birds and lowering mortality rates.
Pasture-raised cattle in North and South Kivu frequently face complex endo- and ectoparasitic pressures. An oral suspension combining Ivermectin and Albendazole targets key parasite life cycles, improving feed conversion ratios without requiring costly injection gear.
Small-scale livestock farmers need user-friendly remedies. Probiotic and enzyme oral liquids require no complex veterinary training to administer, helping to reduce herd morbidity and limit the overuse of traditional antibiotics.
Specific veterinary medicines designed to address targeted health issues, from coccidiostats to functional liver tonics.
Navigating regulatory registration, port logistics, and product validation for smooth commercial imports.
We supply complete Common Technical Documents (CTD), bioequivalence data, and Free Sale Certificates (FSC) to simplify authorization with the Autorité Congolaise de Réglementation Pharmaceutique (ACOREP).
Our logistical teams pack shipments to withstand thermal exposure during marine transit to Matadi or air transport to Kinshasa Ndjili Airport, preserving product stability.
We offer exclusive distribution agreements, technical training, and co-branded promotional assets to established pharmaceutical wholesalers in the DRC.
Essential technical and logistical details for importing veterinary oral products into the Democratic Republic of the Congo.
Our formulations use proprietary chemical stabilizers and buffer agents to prevent hydrolysis and oxidation. We package these solutions in high-density polyethylene (HDPE) containers that seal out moisture and UV light, ensuring long-term active ingredient stability.
We supply full technical files, including Certificates of Analysis (COA), GMP Certificates, Certificate of Pharmaceutical Product (CPP), Stability Testing Reports (under Zone IVB conditions), and complete batch manufacturing records.
Yes. Working alongside Chinese research institutes and custom synthesis labs, we can scale specialized intermediates from benchtop validation up to pilot and commercial-scale batches.
Standard formulations usually ship within 30 to 45 days of order confirmation and deposit. Custom synthesis timelines vary based on chemical complexity, but we provide estimated project schedules at the outset.
A broad range of high-efficacy veterinary pharmaceuticals, including critical antimicrobials, coccidiostats, and nutritional liquids.
Get in touch with our technical team to discuss API profiles, custom chemical synthesis, and secure distribution solutions for the Democratic Republic of the Congo.
Send Inquiry Now
SJ medical
